Allspring Global Investments Holdings LLC Has $5.63 Million Stock Holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Allspring Global Investments Holdings LLC reduced its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 11.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 355,627 shares of the company’s stock after selling 44,337 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in BlackRock Health Sciences Term Trust were worth $5,633,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of BMEZ. Sanctuary Advisors LLC bought a new position in shares of BlackRock Health Sciences Term Trust during the second quarter worth approximately $3,179,000. Quarry LP grew its holdings in BlackRock Health Sciences Term Trust by 304.9% in the 2nd quarter. Quarry LP now owns 98,886 shares of the company’s stock valued at $1,519,000 after buying an additional 74,463 shares in the last quarter. Almitas Capital LLC increased its position in BlackRock Health Sciences Term Trust by 89.3% during the 2nd quarter. Almitas Capital LLC now owns 1,761,943 shares of the company’s stock worth $27,063,000 after buying an additional 831,025 shares during the period. Sessa Capital IM L.P. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 27.1% during the second quarter. Sessa Capital IM L.P. now owns 1,853,022 shares of the company’s stock worth $28,462,000 after buying an additional 395,288 shares in the last quarter. Finally, Logan Stone Capital LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust during the second quarter worth $1,770,000.

Insider Activity at BlackRock Health Sciences Term Trust

In related news, major shareholder Saba Capital Management, L.P. acquired 15,455 shares of the company’s stock in a transaction on Thursday, September 19th. The stock was purchased at an average cost of 16.14 per share, with a total value of 249,443.70. Following the acquisition, the insider now directly owns 20,601,568 shares of the company’s stock, valued at approximately 332,509,307.52. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Over the last ninety days, insiders purchased 99,630 shares of company stock worth $1,585,113.

BlackRock Health Sciences Term Trust Stock Performance

BMEZ stock opened at 15.54 on Monday. BlackRock Health Sciences Term Trust has a 52 week low of 12.93 and a 52 week high of 16.59. The company’s 50-day simple moving average is 15.85 and its 200 day simple moving average is 15.48.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th will be given a $0.176 dividend. The ex-dividend date of this dividend is Tuesday, October 15th. This represents a $2.11 dividend on an annualized basis and a dividend yield of 13.59%.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.